FDA Import Refusal SCS-1063236-4/11/1 — Dabur India Limited (Unit-2)
The FDA refused shipment SCS-1063236-4/11/1 from Dabur India Limited (Unit-2) (India) on Jul 31, 2020. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 31, 2020
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66VCR99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75